WASHINGTON – The Association for Accessible Medicines (AAM) and its board of directors announced the promotion of Christine Simmon to executive vice president, Policy and Strategic Alliances. She also serves as executive director of the Biosimilars Council, the AAM subsidiary that advocates for greater access for patients to biosimilar medicines. She is the executive sponsor
WASHINGTON — Joe Russo is joining the Association for Accessible Medicines Tuesday as senior director, Federal Government Affairs. Joe will help develop the association’s strategy and implement the initiatives of AAM’s government affairs department. He is responsible for managing a range of government relations initiatives and projects to promote the federal policy goals and objectives
WASHINGTON – On the occasion of the one-year anniversary of the U.S.-Mexico-Canada Agreement coming into force, the Association for Accessible Medicines (AAM) releases the following statement: “One year ago today, the U.S.-Mexico-Canada Agreement set the standard for a modern trade agreement. By balancing support for pharmaceutical innovation with generic and biosimilar competition, USMCA is a
WASHINGTON – The Association for Accessible Medicines (AAM)announced that Erik Komendant has been named senior vice president, Government Affairs effective immediately. He will be responsible for the vision, strategic planning, and implementation of AAM’s federal and state advocacy agenda. He previously served as vice president of Federal Government Affairs for the association. Dan Leonard, president
